Ironwood Pharmaceuticals | Actif À Court Terme



Current Assets Changement Date
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Almirall EUR 693.24M 29.14M 2024-06
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amarin USD 650.22M 51.62M 2024-09
Ardelyx USD 356.45M 72.35M 2024-12
Astellas Pharma JPY 1.2T 904M 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Charles River Laboratories USD 1.4B 91.65M 2024-12
Exact Sciences USD 1.57B 38.31M 2024-12
Halozyme Therapeutics USD 1.09B 41.64M 2024-12
Incyte USD 3.24B 430.32M 2024-12
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Moderna USD 8.1B 1.57B 2024-12
Myriad Genetics USD 298M 4.8M 2024-12
Pacira USD 745.13M 55.16M 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Takeda JPY 2.75T 299.73B 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12



Ironwood Pharmaceuticals Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.